Genes of intestinal Escherichia coli and their relation to the inflammatory activity in patients with ulcerative colitis and Crohn's disease

Folia Microbiologica

Volumn 56, Issue 5, 2011, Pages 367-372

  Gombošová, Laura ^a   Lazurova I ^a   Zakuciova M ^a   Curova K ^a   Kmetova M ^a   Petrasova D ^a   Siegfried, L ^a  

^a P J AFÁRIK UNIVERSITY   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; FIMBRIA PROTEIN; FIMBRILLIN; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BACTERIUM IDENTIFICATION; BIOSYNTHESIS; CASE CONTROL STUDY; CROHN DISEASE; CZECH REPUBLIC; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; INFLAMMATION; INTESTINE; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; POLYMERASE CHAIN REACTION; ULCERATIVE COLITIS;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; CZECH REPUBLIC; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; FIMBRIAE PROTEINS; HUMANS; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-6; INTERLEUKIN-8; INTESTINES; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

ESCHERICHIA COLI;

EID: 80053624904     PISSN: 00155632     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12223-011-0051-z     Document Type: Article

References (26)

1. Best WR, Becktel JM, Singleton JW et al (1976) Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 70: 439-444.
2. Boudeau J, Barnich N, Darfeuille-Michaud A (2001) Type 1 pili-mediated adherence of E. coli strain LF82 isolated from Crohn's disease is involved in bacterial invasion of intestinal epithelial cells. Mol Microbiol 39: 1272-1284.
3. Chamberli WM, Naser SA (2006) Integrating theories of the etiology of Crohn's disease: questioning the hypotheses. Med Sci Monit 12: 27-33.
4. Denis MA, Reenaers C, Fontaine F et al (2007) Assessment of endoscopic activity index and biological inflammatory markers in clinically active Crohn's disease with normal C-reactive protein serum level. Inflamm Bowel Dis 13: 1100-1105.
5. Dignass AU, Baumgart DC, Sturm A (2004) Review article: the etiopathogenesis of inflammatory bowel disease-immunology and repair mechanisms. Aliment Pharmacol Ther 20(suppl V): 9-17.
6. Dogan B, Simpson KW (2008) Microflora in Crohn's disease: the emergence of adherent and invasive Escherichia coli. Expert Rev Clin Immunol 4: 133-137.
7. Douda T, Bureš J, Rejchrt S (2006) Mean platelet volume in Crohn's disease patients. Cas Lek Cesk 145: 870-873.
8. Fantini MC, Monteleone G, MacDonald TT (2007) New players in the cytokine orchestra of inflammatory bowel disease. Inflamm Bowel Dis 13: 1-5.
9. Florin TH, Paterson EW, Fowler EV (2006) Clinically active Crohn's disease in the presence of a low C reactive protein. Scand J Gastroenterol 41: 306-311.
10. Guarner F, Malagelada JR (2003) Role of bacteria in experimental colitis. Best Pract Res Clin Gastroenterol 17: 793-804.
11. Irving PM, Pasi KJ, Rampton DS (2005) Thrombosis and inflammatory bowel disease. Clin Gastroenterol Hepatol 3: 617-628.
12. Kuhnert P, Hacker J, Muhldorfer I et al (1997) Detection system for Escherichia coli-specific virulence genes: absence of virulence determinants in B and C strains. Appl Environ Microbiol 63: 703-709.
13. Liptáková A, Sehnálková H, Sabol M et al (2001) Detection of shiga-like toxin producing Escherichia coli by multiplex PCR. Biologia Bratislava 56: 65-68.
14. Macfarlane S, Steed H, Macfarlane GT (2009) Intestinal bacteria and inflammatory bowel disease. Crit Rev Clin Lab Sci 46: 25-54.
15. Martin HM, Campbell BJ, Hart CA et al (2004) Enhanced E. coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology 127: 1649-1650.
16. Mitsuyama K, Tomiyasu N, Takaki K (2006) IL-10 in the pathophysiology of inflammatory bowel disease: increased serum concentrations during the recovery phase. Med Inflamm 1: 1-7.
17. Mudter J, Neurath MF (2007) IL-6 signaling in inflammatory bowel disease: pathophysiology role and clinical relevance. Inflamm Bowel Dis 13: 1016-1023.
18. Nielsen OH, Rudiger N, Gaustadnes M et al (1997) Intestinal interleukin-8 concentration and gene expression in inflammatory bowel disease. Scand J Gastroenterol 32: 1028-1034.
19. Reinecker HC, Steffen M, Witthoeft T et al (1993) Enhanced secretion of tumour necrosis factor-α, IL-6, and IL-1β by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 94: 174-181.
20. Sanchez-Muñoz F, Dominguez-Lopez A, Yamamoto Furusho JK (2008) Role of cytokines in inflammatory bowel disease. World J Gastroenterol 14: 4280-4288.
21. Sansonetti PJ, Arondel J, Huerre M (1999) IL-8 controls bacterial transepithelial translocation at cost of epithelial destruction in experimental shigellosis. Infect Immun 67: 1471-1480.
22. Sasaki M, Sitaraman SV, Babbin BA et al (2007) Invasive Escherichia coli are a feature of Crohn's disease. Lab Invest 87: 1042-1054.
23. Scaldaferri F, Fiocchi C (2007) Inflammatory bowel disease: progress and current concepts of etiopathogenesis. J Dig Dis 8: 1-9.
24. Schroeder KW, Tremaine WJ, Ilstrup DM (1987) Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis: a randomised study. New Engl J Med 317: 1625-1629.
25. Vermèire S, van Assche G, Rutgeerts P (2006) Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut 55: 426-431.
26. Yamamoto S, Terai A, Yuri K et al (1995) Detection of virulence factors in Escherichia coli by multiplex polymerase chain reaction. FEMS Immunol Med Microbiol 12: 85-90.